393 related articles for article (PubMed ID: 24764665)
1. Advances in epigenetic biomarker research in colorectal cancer.
Wang X; Kuang YY; Hu XT
World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers in colorectal cancer: premises and prospects.
Zamani M; Hosseini SV; Mokarram P
Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Biomarkers in Colorectal Cancer.
Verma M; Kumar V
Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
6. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance.
Baharudin R; Rus Bakarurraini NQ; Ismail I; Lee LH; Ab Mutalib NS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806286
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
10. Value of methylation markers in colorectal cancer (Review).
Kong C; Fu T
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34212989
[TBL] [Abstract][Full Text] [Related]
11. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
Okugawa Y; Grady WM; Goel A
Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
[TBL] [Abstract][Full Text] [Related]
16. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
Gezer U; Holdenrieder S
In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.
Hashimoto Y; Zumwalt TJ; Goel A
Epigenomics; 2016 May; 8(5):685-703. PubMed ID: 27102979
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
Fatemi N; Tierling S; Es HA; Varkiani M; Mojarad EN; Aghdaei HA; Walter J; Totonchi M
Int J Cancer; 2022 Dec; 151(12):2068-2081. PubMed ID: 35730647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
